DANIEL P JUDGE

Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology CHARLESTON, SC NPI 1790726917

General Payments — all program years on this page

$129,733.48

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 68
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $33,801.22 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $21,273.254
Travel and Lodging $12,014.013
Food and Beverage $513.965

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $25,192.065
Alnylam Pharmaceuticals Inc. $7,885.685
Acerta Pharma LLC $537.001
Edwards Lifesciences Corporation $186.481

By program year

Program yearAmountRecords
2018 $31,080.4916
2019 $18,645.3418
2020 $10,200.004
2021 $2,290.444
2022 $7,645.004
2023 $26,070.9910
2024 $33,801.2212

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096552019 Novo Nordisk AS $263.38 05/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552299 Novo Nordisk AS $10,879.55 05/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552689 Novo Nordisk AS $196.80 05/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552875 Novo Nordisk AS $12,981.25 05/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096553425 Novo Nordisk AS $871.08 05/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105266032 AstraZeneca Pharmaceuticals LP $537.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125826977 Alnylam Pharmaceuticals Inc. $40.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125826979 Alnylam Pharmaceuticals Inc. $35.68 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125826981 Alnylam Pharmaceuticals Inc. $55.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125826997 Alnylam Pharmaceuticals Inc. $4,935.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125827071 Alnylam Pharmaceuticals Inc. $2,820.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1138837872 Edwards Lifesciences Corporation $186.48 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.